| 摘要 |
<p>The invention concerns aniline derivatives of formula (I) wherein m is 1, 2 or 3 and each R1 includes halogeno, hydroxy, amino, hydroxyamino, ureido, trifluoromethoxy and (1-4C)alkyl; n is 0, 1, 2 or 3 and each R2 includes halogeno, trifluoromethyl, hydroxy, amino, nitro, cyano and (1-4C)alkyl; X is a group of the formula CO, C(R3)2, CH(OR3), C(R3)2-C(R3)2, C(R3)=C(R3), C=C, CH(CN), O, S, SO, SO2, CONR3, SO2NR3, NR3CO, NR3SO2, OC(R3)2, SC(R3)2, C(R3)2O or C(R3)2S wherein each R3 is independently hydrogen or (1-4C)alkyl; and Q is a phenyl or naphthyl group or a 5- or 6-membered heteroaryl moiety containing 1, 2 or 3 heteroatoms selected from oxygen, nitrogen and sulphur; or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them, and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of proliferative disease such as cancer.</p> |
